RecruitingNCT06923449

Gastric Cancer' Textbook Oncological Outcome and Tumor Board Performance

Gastric Cancer' Textbook Oncological Outcome and Tumor Board Performance - The Experience of a High-volume Italian University Hospital


Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Enrollment

250 participants

Start Date

May 16, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational, no-profit, spontaneous, retrospective, monocentric study is to compare surgical and oncologic outcomes in patients affected by gastric cancer before and after the institution of the Tumor Board, a multidisciplinary weekly case discussion. The main question it aims to answer is whether the Textbook Outcome (TO) and Textbook Oncological Outcome (TOO) of patients with non-early, non-metastatic gastric cancer undergoing surgical treatment with curative intent have improved before (from January 2018 to November 2019) and after (from December 2019 onwards) the establishment of the Multidisciplinary Tumor Board (MTB) at Fondazione Policlinico Gemelli (FPG).


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • pathology-confirmed diagnosis of gastric adenocarcinoma
  • age 18 years or older
  • surgical candidates with curative intent

Exclusion Criteria8

  • Endoscopic Mucosal Resection (EMR) or Endoscopic Submucosal Dissection (ESD)
  • previous EMR or ESD (salvage surgery)
  • histologies other than adenocarcinoma (no squamous cell carcinomas, GISTs, sarcomas, lymphomas, etc)
  • unsufficient staging (unclear clinical stage at diagnosis)
  • emergency presentation (obstrucetd, significantly bleeding, perforated gastric cancer)
  • synchronous tumors affecting survival
  • pregnant patients
  • age \<18years

Interventions

OTHERMultidisciplinary Tumor Board

Institution of Multidisciplinary Tumor Board for Gastric Cancer at Fondazione Policlinico Gemelli in november 2019


Locations(1)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Rome, IT, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06923449


Related Trials